Clinical trial
An Open Label Treatment Extension Study of AMG 706
NCT00360867 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Treatment Extension Study of AMG 706
- Lead sponsor
- Amgen
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 31, 2005
- Completion date
- July 31, 2012
- Enrollment
- 94 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors